Upgrade to SI Premium - Free Trial

Lam Research (LRCX): Further Downside to Lowered Capex Expectations - Lynx Equity Strategies

January 22, 2019 8:22 AM
Lynx Equity Strategies analysts KC Rajkumar and Jahanara Nissar weighed in on Lam Research (NASDAQ: LRCX) and sees further downside ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View

Next Articles